Collegium Pharmaceutical (COLL) Return on Sales: 2017-2025
Historic Return on Sales for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to 0.08%.
- Collegium Pharmaceutical's Return on Sales fell 7.00% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of 0.07% for FY2024, which is 1.00% down from last year.
- As of Q3 2025, Collegium Pharmaceutical's Return on Sales stood at 0.08%, which was up 50.47% from 0.05% recorded in Q2 2025.
- In the past 5 years, Collegium Pharmaceutical's Return on Sales registered a high of 0.33% during Q2 2021, and its lowest value of -0.12% during Q3 2022.
- Over the past 3 years, Collegium Pharmaceutical's median Return on Sales value was 0.08% (recorded in 2025), while the average stood at 0.07%.
- As far as peak fluctuations go, Collegium Pharmaceutical's Return on Sales surged by 33bps in 2021, and later slumped by 44bps in 2022.
- Over the past 5 years, Collegium Pharmaceutical's Return on Sales (Quarterly) stood at 0.26% in 2021, then plummeted by 31bps to -0.05% in 2022, then rose by 14bps to 0.08% in 2023, then rose by 2bps to 0.11% in 2024, then decreased by 7bps to 0.08% in 2025.
- Its Return on Sales stands at 0.08% for Q3 2025, versus 0.05% for Q2 2025 and 0.07% for Q1 2025.